Prognostic value of Ki67 antigen expression in basal cell carcinomas
Prognostic value of Ki67 antigen expression in basal cell carcinomas
Recurrence of basal cell carcinoma (BCC) following treatment is a common event and long-term follow-up of all patients presenting with a primary BCC has been recommended. Proliferation indices have been recognized as important prognostic factors in several tumour types in a variety of cancer systems, being significantly elevated in more aggressive lesions. We have examined 51 BCCs (17 non-recurrent tumours [group 1], 17 original tumours which later recurred [group 2-O], and the corresponding 17 recurrent specimens [group 2-R]) for Ki67 antigen expression, a proliferation-associated antigen using immunohistochemistry with the monoclonal antibody MIB1. There was a significant increase in the percentage positive for MIB1 in the Group 2-O as compared with the group 1 BCCs (P<0.05). p53 protein expression, as assessed by immunohistochemistry with the monoclonal antibody DO7, was similar in each group. These results show that Ki67 antigen expression differs between BCCs which later recur and BCCs that do not recur.
737-741
Healy, E.
400fc04d-f81a-474a-ae25-7ff894be0ebd
Angus, B.
899f2303-e814-4e39-ab5b-da7306cfdac5
Lawrence, C.M.
c1eab9bb-933d-4b69-81ed-203a6464170e
Rees, J.L.
4884fa5d-84c0-45da-b2a3-a096bfd21c9b
November 1995
Healy, E.
400fc04d-f81a-474a-ae25-7ff894be0ebd
Angus, B.
899f2303-e814-4e39-ab5b-da7306cfdac5
Lawrence, C.M.
c1eab9bb-933d-4b69-81ed-203a6464170e
Rees, J.L.
4884fa5d-84c0-45da-b2a3-a096bfd21c9b
Abstract
Recurrence of basal cell carcinoma (BCC) following treatment is a common event and long-term follow-up of all patients presenting with a primary BCC has been recommended. Proliferation indices have been recognized as important prognostic factors in several tumour types in a variety of cancer systems, being significantly elevated in more aggressive lesions. We have examined 51 BCCs (17 non-recurrent tumours [group 1], 17 original tumours which later recurred [group 2-O], and the corresponding 17 recurrent specimens [group 2-R]) for Ki67 antigen expression, a proliferation-associated antigen using immunohistochemistry with the monoclonal antibody MIB1. There was a significant increase in the percentage positive for MIB1 in the Group 2-O as compared with the group 1 BCCs (P<0.05). p53 protein expression, as assessed by immunohistochemistry with the monoclonal antibody DO7, was similar in each group. These results show that Ki67 antigen expression differs between BCCs which later recur and BCCs that do not recur.
This record has no associated files available for download.
More information
Published date: November 1995
Organisations:
Clinical & Experimental Sciences
Identifiers
Local EPrints ID: 334164
URI: http://eprints.soton.ac.uk/id/eprint/334164
ISSN: 0007-0963
PURE UUID: 83ff93e7-7a21-4c63-9bf7-216e6cd73f14
Catalogue record
Date deposited: 16 Mar 2012 10:17
Last modified: 14 Mar 2024 10:33
Export record
Altmetrics
Contributors
Author:
B. Angus
Author:
C.M. Lawrence
Author:
J.L. Rees
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics